Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Week 40

September 28 – October 4, 2026 · 2 articles

Clinical · Molecular biology · Bioinfo & AI

Latent Class Analysis-Derived Classification and Cancer-Specific Death in Endometrial Carcinoma: A Population-Based Cohort Study

Zhao S, Cheng J, Wang H, et al.

JCO precision oncology

This study developed a novel clinical classification for endometrial carcinoma (EC) using latent class analysis (LCA) on a large cohort of 46,772 cases from the SEER program. Five clinically interpretable classes emerged, each associated with distinct risks of cancer-specific mortality (CSM) and TCGA molecular subtypes. Integrating this LCA classification into molecular survival models improved prognostic discrimination. Furthermore, class-specific transcriptomic signatures involving metabolic reprogramming, DNA repair, and immune pathways were identified. The benefits of combined treatments (surgery, radiotherapy, chemotherapy) varied significantly by class, suggesting a more personalized therapeutic approach.

Clinical · Molecular biology

Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis

Gao R, Li Z, Huang J, et al.

Lung cancer (Amsterdam, Netherlands)

This multicenter retrospective study analyzed 163 patients with transformed small-cell lung cancer (T-SCLC), a recognized resistance mechanism in EGFR-mutant lung adenocarcinoma. The study aimed to identify early predictors of histological transformation and evaluate post-transformation treatment outcomes. Researchers found a median transformation time of 25.8 months and a median post-transformation overall survival of 14.2 months in EGFR-mutant patients. A predictive model was developed, incorporating age, RB1/NTRK1 mutations, and secondary EGFR T790M mutation as independent risk factors. Taxane-based regimens emerged as a promising later-line therapeutic option for T-SCLC.